| # | Drug | Count |
|---|---|---|
| 0 | ATAZANAVIR | 26 |
| 1 | DARUNAVIR | 25 |
| 2 | RITONAVIR | 25 |
| 3 | NEVIRAPINE | 16 |
| 4 | ENALAPRIL | 10 |
| 5 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 9 |
| 6 | METHYLDOPA | 9 |
| 7 | LOPINAVIR AND RITONAVIR | 7 |
| 8 | NIFEDIPINE | 6 |
| 9 | OLANZAPINE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ABACAVIR AND LAMIVUDINE | 1 | 0.0050 |
| 1 | ACONITUM NAPELLUS, ARSENIC TRIOXIDE, ATROPA BELLADONNA, BRYONIA ALBA ROOT, EUPATORIUM PERFOLIATUM FLOWERING TOP, FERRUM PHOSPHORICUM, GELSEMIUM SEMPERVIRENS ROOT | 1 | 0.0024 |
| 2 | METHYLDOPA | 9 | 0.0018 |
| 3 | ATAZANAVIR | 26 | 0.0018 |
| 4 | NEVIRAPINE | 16 | 0.0018 |
| 5 | DARUNAVIR | 25 | 0.0017 |
| 6 | LOPINAVIR AND RITONAVIR | 7 | 0.0005 |
| 7 | EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR ALAFENAMIDE | 1 | 0.0003 |
| 8 | DOLUTEGRAVIR SODIUM | 2 | 0.0002 |
| 9 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 9 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Protease Inhibitor [EPC] | 32 | 0.0007 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 16 | 0.0007 |
| 2 | Cytochrome P450 3A Inhibitor [EPC] | 32 | 0.0005 |
| 3 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 13 | 0.0001 |
| 4 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 5 | Anti-epileptic Agent [EPC] | 6 | 0.0000 |
| 6 | 5-alpha Reductase Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Dihydropyridine Calcium Channel Blocker [EPC] | 6 | 0.0000 |
| 8 | Mood Stabilizer [EPC] | 4 | 0.0000 |
| 9 | Atypical Antipsychotic [EPC] | 8 | 0.0000 |